Actively Recruiting
Assessing the Impact of Additional Serratus Anterior Block Within 24 Hours on Postoperative Pain After Rhomboid Intercostal Block in VATS Patients
Led by Al-Quds University · Updated on 2025-08-28
50
Participants Needed
1
Research Sites
26 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating whether adding a Serratus Anterior Plane Block (SAPB) to the standard Rhomboid Intercostal Block (RIB) improves postoperative pain control in patients undergoing Video-Assisted Thoracoscopic Surgery (VATS). This randomized controlled trial addresses the challenge of pain after VATS, aiming to reduce opioid use and improve patient satisfaction by combining two regional anesthesia techniques targeting different nerve pathways. Participants are divided into two groups: one receives RIB alone, and the other receives RIB plus SAPB within 24 hours after RIB. Both blocks are performed under ultrasound guidance to provide targeted pain relief. The study compares pain levels, opioid consumption, and patient satisfaction between the two groups during the first 48 hours after surgery. During the study, pain severity will be measured using the Visual Analog Scale (VAS) at multiple time points within 48 hours post-surgery. Researchers will also track opioid use and collect patient satisfaction data through questionnaires. Safety and any adverse effects related to the anesthesia techniques will be monitored. The trial involves adult patients aged 18 to 70 undergoing VATS, with participation lasting through the immediate postoperative period for assessment.
CONDITIONS
Brief Title
Assessing the Impact of Additional Serratus Anterior Block Within 24-Hour on Postoperative Pain After Rhomboid Intercostal Block in VATS Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 to 70 years
- Undergoing Video-Assisted Thoracoscopic Surgery (VATS)
- Classified as ASA physical status I-III (low to moderate surgical risk)
- Able to provide informed consent and follow study procedures
You will not qualify if you...
- Known allergy or hypersensitivity to local anesthetics
- Bleeding disorders or use of anticoagulants
- History of chronic opioid use or opioid dependence
- Chest wall deformities or conditions preventing regional anesthesia
- Neurological disorders affecting pain perception
- Cognitive impairments, language barriers, or inability to communicate effectively
- Pregnancy or breastfeeding
- Refusal or inability to provide informed consent
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 48 hours post-surgery
Participants undergo Video-Assisted Thoracoscopic Surgery (VATS) and receive regional anesthesia for postoperative pain control. One group receives Rhomboid Intercostal Block (RIB) only, while the other group receives RIB plus an additional Serratus Anterior Plane Block (SAPB) within 24 hours after RIB.
1 baseline visit on surgery day and up to 2 visits within 48 hours post-surgery
Trial Site Locations
Total: 1 location
1
Al Ahli hospital
Hebron, Palestinian Territories
Actively Recruiting
Research Team
M
Mohammed Adel Adwan, MD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here